Expansion momentum TransMedics is rapidly expanding its geographic footprint, with plans to move its headquarters to Somerville, Massachusetts in 2028, expand offices in Massachusetts, and initiate international growth into Italy and Europe via strategic investments and an international NOP-inspired model. This presents opportunities to cross-sell or establish partnerships with transplant centers and hospitals in new regions leveraging the Organ Care System (OCS).

Revenue growth signals Recent reported Q1 2026 revenue of approximately $174 million indicates strong demand for Organ Care System technology, suggesting a receptive market for expanded deployment, service contracts, and training, as centers look to upgrade from static cold storage to OCS-based organ preservation and assessment.

Global access play Strategic investment in PAD Aviation GmbH to extend the NOP model internationally implies a need for logistics solutions, 24/7 clinical support, and transport infrastructure. This creates sales opportunities for integrated logistics services, air and ground transport packages, and remote-onboarding support for new transplant centers abroad.

Portfolio expansion With FDA-approved OCS technology for lung, heart, and liver transplants and a nationwide clinical support network, there is potential to upsell expanded usage, training programs, and maintenance packages to existing customers while targeting hospitals expanding transplant programs or upgrading to OCS for additional organ indications.

Strategic partnerships The combination of large-scale funding, ambitious hiring plans, and a push into new markets signals openness to collaborations with major medical centers, health systems, and regional distributors. Propose co-development, pilot programs, and bundled offerings that integrate OCS hardware, software (Workday, analytics), and service tiers to accelerate adoption.